Evaluation of Benztropine for Cocaine Craving - 2

The purpose of this study is to compare the efficacy of benztropine (or DA reuptake inhibitor) with atropine and placebo in affecting stimulated craving to cocaine cues.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

22 year–48 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Washington DC VA

Washington D.C., District of Columbia, 20422, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Benztropine

Drug

Primary outcomes

Stimulated and non-stimulated craving

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

Washington D.C. Veterans Affairs Medical Center

Registry information

Official study title

Evaluation of Efficacy of Benztropine for Cocaine Craving

Important dates

Study start: 2001
Primary completion: 2003
Study completion: 2003
First posted: Sep 21, 1999
Registry last updated: Feb 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed